1 Hong Kong College of Medical Nursing LG1, School of Nursing, Princess Margaret Hospital, 232 Lai King Hill Road, Lai Chi Kok, Kowloon, Hong Kong Website: http://www.hkcmn.com Email address: [email protected]Endorsed on: 10 April 2017 Hong Kong College of Medical Nursing Advanced Practice Nursing (Medicine) Certification Program Syllabus of Fellow Membership Examination (Sub-Specialty Module)
38
Embed
Hong Kong College of Medical Nursing Advanced Practice ... · PDF file2.2.2 Advocate and implement evidence-based practice in daily nursing care of acute ... diagnosis and care plan
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Hong Kong College of Medical Nursing
Advanced Practice Nursing Certification Program
Specialty Module for Preparing Fellowship Exit Examination
Syllabus
Hong Kong College of Medical Nursing
LG1, School of Nursing, Princess Margaret Hospital, 232 Lai King Hill Road,
Advanced Practice Nursing (Medicine) Certification Program Syllabus of Fellow Membership Examination (Sub- Specialty Module)
Table of Contents:
I INTRODUCTION……………………………………………………………………………………………………………..3
II GOALS AND LEARNING OBJECTIVES………………………………………………………………………………3-4
III TRAINING ARRANGEMENT OF THE SUB-SPECIALTY MODULE………………….………..…………….…4-5
IV ENTRY REQUIREMENT …………………………………………………………………………………………………..5
V HAEMATOLOGY NURSING …………………………………………………………………………………......…6-10
VI ONCOLOGY NURSING……………………………………………………………………………………………….11-15
VII RENAL NURSING………………………………………………………………………………………………………16-22
VIII RESPIRATORY NURSING……………………………………………………………………………………………23-25
IX RHEUMATOLOGY NURISNG……………………………………………………………………………………..26-29
COURSE CALENDER ………………………………………………………………….…………………………………..11 X COURSE CALENDER………………………………………………………………………………………………………30
XI FELLOW MEMBERSHIP EXIT ASSESSMENT …………………………………………………….…………30-31
XII AWARD ……………………………………………………………………..……………………………………….……….31
XIII APPENDIX ………………………………………………………………………………………………………………32-37
-ROAD MAP
-THE COMPETENCE FRAMEWORK OF 7 DOMAINS
ATTACHMENT
- CLINICAL LOG BOOK – Haematology Nursing - CLINICAL LOG BOOK – Oncology Nursing - CLINICAL LOG BOOK – Renal Nursing - CLINICAL LOG BOOK – Respiratory Nursing
- CLINICAL LOG BOOK - Rheumatology Nursing =
- CLINICAL LOG BOOK – Rehabilitation - CLINICAL LOG BOOK – Rheumatology
3
I Introduction
1.1 For nurses who desired to be Fellow Members of Advanced Practice of the Hong Kong College of Medical Nursing (HKCMN), they must pass the Membership Exit Examination and gain the award of Ordinary Members of HKCMN and HKAN respectively, and then they will take one of the Sub-Specialty Modules (provided they have acquired a minimum of 1 year in the sub-specialty prior to obtaining Ordinary Member award) to prepare for the Fellow Membership Exit Assessment. (appendix 1)
1.3 The S u b - Specialty Module aims to provide a compressive range of advanced practice strategies to facilitate the Ordinary Members of HKCMN/HKAN to polish his/her skills and knowledge in relation to Medical Nursing. Through practice, the candidates will integrate the theory and practice to build up unique professional knowledge and practice to enhance the medical nursing services provision, enabling the patients and families to cope with the illness episodes, to promote and protect their health. The candidates will lead the development of quality improvement programs to minimize risk- prone activities for betterment of healthcare services. To enhance healthcare for community at large, the candidates will advocate and participate actively in health care policy.
II Goals and Learning Objectives
2.1 The S u b - Specialty Module is designed to prepare nurses working in medical related healthcare area to fulfill the training requirement to sit for the fellow membership assessment organized by HKCMN.
2.2 Learning objectives :
Upon completion of the Sub-specialty Module, the Candidate shall be able to :
2.2.1 Master and apply the contemporary and advanced health care knowledge in caring patients and families with acute / chronic medical diseases in various health care settings
2.2.2 Advocate and implement evidence-based practice in daily nursing care of acute / chronic medical patients of the following s u b - specialties: Advanced Medicine, Hematology; Infectious Disease; Neurology; Oncology; Palliative; Rehabilitation: Renal; Respiratory; Rheumatology;
2.2.3 Initiate comprehensive assessment, screening to facilitate the diagnosis
2.2.4 Analyze the support system to identify factors related to the family, social support and coping mechanism to facilitate the patient(s) recovery and/or rehabilitation through the illness episode(s)
2.2.5 Implement and evaluate therapeutic interventions
2.2.6 Identify etiology, pathogenesis and clinical manifestation of the disease(s)
4
2.2.7 Work in partnership with the healthcare team to interpret laboratory and other diagnostic tests for differential diagnosis and care plan formulation
2.2.8 Identify patients with deteriorating conditions early and enables patient to receive appropriate treatment promptly
2.2.9 Maintain treatment regimens recognizing the pharmacodynamics and pharmacokinetic processes
2.2.10 Exercise professional autonomy and decision making in clinical case management with interventions as indicated and coordinate multi-disciplinary approach treatment plan
2.2.11 Promote health to patients and their families to enforce health life styles 2.2.12 Strengthen cross specialties / cross hospital (s) / community resources to improve service
delivery to meet complex patient care needs.
2.2.13 Initiate and lead nursing research to enhance nursing care practice in medical patient management.
III Training Arrangement of the Sub-Specialty Module
3.1 The duration of the Sub-Specialty Module including theory and clinical practice should be of a minimum of 1 year and not more than 2 years.
3.2 To fulfill the requirement, the candidates should in addition to attending the Advanced Practice Nursing Certification S u b - Specialty Module Program organized by HKCMN; they are to pursue healthcare related specialty training programs organized by external institutions to enrich their knowledge.
3.3 Criteria for accreditation :
- Organizing institutions whom are CNE providers accredited by the Nursing Council of Hong Kong or accredited/ recognized education providers in Hong Kong
- The program is structured to map the competency framework (Appendix 2) of HKCMN
3.4 The Candidates are to log the clinical experience into the respective Clinical Log Book, produce evidence of learning and be assessed by a designated mentor. The clinical learning experiences are to be carried out in various healthcare institutions accredited by HKCMN.
3.5 Criteria of Accredited training sites:
- The hospital/ health care institution is preferably accepted training ground by the Nursing Council of Hong Kong
- The hospital management is supportive to the training by setting conducive learning environment
- Learning resources are available such as library, e learning resources - Continuous professional development system is available - Workload are at an optimal level to facilitate learning
3.6 Criteria of Mentors - Fellow of HKAN and appointed by HKCMN - Actively engaged in the practice of Nursing - Able to conduct training in accredited training programs - Cannot hold trainer status in more than 2 subspecialties - Cannot at the same time undergo specialty training in any other subspecialties within
the Academy Colleges - He/she cannot take more than 3 trainees.
5
3.7 Evidence of Learning: - Reflective learning paper - Active participation in nurse rounds - Research project related to the working areas - Paper presentation in a local or international conference - Leading quality improvement/patient safety activities - Initiate a new project/ program in practice - Handling of complicated patient episode(s)
IV Entry Requirement
4.1 Entry requirement for Fellow Exit Assessment - Holder of a valid Registered Nurse (RN) Certificate issued by the Nursing Council of Hong Kong
and with valid Practicing Certificate - Accepted as the Ordinary Member of Hong Kong College of Medical Nursing and Hong Kong
Academy of Nursing - Worked in medical nursing related specialty for at least an accumulative 6 years in the most
recent 9 years - With the accumulative 6 years in medical nursing experience of which current 3 years must be
working in related Sub-Specialty area
6
V Haematology Nursing Sub-specialty Module 5.1 Fundamental Module
5.1.1 Haematological Disease: Clinical features, diagnostic criteria and Related Management i. Red Cell Disorders and Anaemia
- Erythropoiesis and Anaemia - Nutritional Anaemia - Iron (Fe) Deficiency Anaemia - Vitamin B12 Deficiency - Folate Deficiency - Paroxysmal Nocturnal Haemoglobinuria (PNH) - Autoimmune Haemolytic Anaemia - Aplastic Anaemia - Red Cell Aplasia - Iron Overload - Thalassemia
ii. White Cell Disorders Neutropenia, Lymphocytosis, lymphopenia, basophilia and basopenia
iii. Platelet Disorders, Haemostasis and Bleeding Disorders - Von Willebrand Disease (vWD) - Haemophilia A and B - Thrombocytopenia - Disseminated Intravascular Coagulation (DIC) - Immune Thrombocytopenic Purpura (ITP) - Acute Venous Thromboembolism (VTE): Heritable thrombophilia, Acquired
thrombophilia, - Inherited bleeding disorders (Haemophilia A, Haemophilia B, Von Willebrand
5.1.2 Ambulatory Medical / Haematology Care and Community Service
i. Patient empowerment - Self-care on: Central Venous Access Devices ( CVADs); Desferroxime
injection - G-CSF injection and factor replacement - Care & education before, during and after chemotherapy, complications
and upon discharge ii. Community and patient collaboration: patient group communication and activities
5.2 Health Assessment Module
5.2.1 Initial assessment on patient newly diagnosed with Haematological malignancies and patient for Haematopoietic Stem Cell Transplantation (HSCT)
5.2.2 Initial assessment on patient for Apheresis procedure 5.2.3 Nutritional assessment for patient undergone HSCT 5.2.4 Oral care and prevention of emesis 5.2.5 Symptomatic based assessment for post chemotherapy complication and neutropenia
5.3 Nursing Care Module
5.3.1 Establishment of patient centered care Therapeutic relationship 5.3.2 Management of patients with blood product transfusion.
5.3.3 Management of patients with Central Venous Access Devices ( CVADs): - Hickman’s catheter - Haemostar catheter - Peripherally Inserted Central Venous Catheter (PICC) - Port-A Cath
5.3.4 Management of patients with complex Haematological conditions: - Haematological Emergencies:
- Neutropenic sepsis 5.3.5 Management of patients with chemotherapy and biotherapy for haematological
malignancies. 5.3.6 Management of Haematopoietic Stem Cell Transplant (Allogeneic and Autologous) patients, including pre and post transplantation coordination and management.
5.3.7 Management of patient with post transplantation relapses. 5.3.8 Management of patient with inherited anaemia. 5.3.9 Management of patient with inherited bleeding disorders. 5.3.10 Management of patients with Acquired coagulation disorders, thrombocytopenia and haemophilia.
5.3.11 Management of patients with Leukemia. 5.3.12 Management of patients with Lymphoma 5.3.13 Management of patients with Multiple Myeloma 5.3.14 Management of patients with Aplastic Anaemia.
8
5.3.15 Management of patients with haematological conditions on palliative care, pain management, psychological support and end of life care . 5.3.16 Management of patients underwent the following procedures: - Bone Marrow Biopsy - Radiotherapy - Intrathecal Chemotherapy - Intravenous access cannulation and blood taking - Stem cell harvest - Stem cell infusion - Pre-transfusion compatibility test: Type and Screen - Human Leukocyte Antigen (HLA) tissue typing - Pentamidine Inhalation - Funding subsidy coordination and follow up 5.3.17 Management of patients with apheresis. - Therapeutic Apheresis - Stem cell harvest 5.3.18 Infection control for haematological and HSCT patients 5.3.19 Management of patients with haematological conditions undergone radiotherapy.
5.4 Development of Nurse Led Clinics 5.5 Legal and ethical issues 5.6 Quality and risk management 5.7 Management and leadership skills 5.8 Facilitate change and adopt evidence-based practice in nursing care
5.9 Design and Framework of Haematology Nursing Sub-Specialty Module The Haematology Nursing Sub-Specialty Module is designed under the competency framework (appendix 2) of HKCMN. Below indicated the Sub-Specialty Module matching the competency framework:
No. Subject Areas Domains
1 2 3 4 5 6 7
Fundamental Module 5.1.1 Haematological Disease: Clinical features, diagnostic criteria and related
management
i. Red Cell Disorders 1,4,5,6,9,11
All 1,3,4,5,6
1 6,7 1
ii. Aplastic Anaemia 1,4,5,
6,9,11
All 1,3,4,
5,6
1 6,7 1
iii. Inherited anaemia (Thalassemia) 1,4,5,
6,9,11
All 1,3,4,
5,6
1 6,7 1
iv. Inherited bleeding disorders
(Hemophilia)
1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
v. White Cell Disorder 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
vi. Platelet, Haemostasis and bleeding
disorders
1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
vii. Plasma cell disorders 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
9
viii. Myelodysplastic Syndromes 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
ix. Myeloproliferative Disease 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
x. Thrombotic thrombocytopenic Purpura
(TTP)
1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
xi. Immune Thrombocytopenic Purpura (ITP) 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
xii. Haematological Malignancies 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
xiii. Haematological Emergencies 1,4,5,
6,9,11 All 1,3,4,
5,6 1 6,7 1
5.1.2 Ambulatory Medical / Haematology Care and Community Service
i. Patient empowerment All 3,4 1,2,3 1
ii. Community and patient collaboration: patient group communication and activities
2,3,4,5,6,7,8,9,10,11
1,3,4,5,8
1,2 13 1
Health Assessment Module
5.2.1 Initial assessment on patient newly diagnosed with Haematological Malignancies and patient for Haematopoietic Stem Cell Transplantation (HSCT)
All All 1,3 1,2,3,5,6
1,3, 4,6
8
5.2.2 Initial assessment on patients for apheresis procedure
All 1,4, 1,3, 4,6
8
5.2.3 Nutritional assessment for patient undergone HSCT
All 1,4, 1,2,3,4
1,2,3,5,6
1,3, 4,6
8
5.2.4 Oral care and prevention of emesis All 1,4, 1,2,3,5,6
1,3, 4,6
6, 8
5.2.5 Symptomatic based assessment for post chemotherapy complication and neutropenia
All 1,2,3,4,5,6,8
1,2,3 1,2,3,5,6
1,3, 4,6
8
Nursing Care Module
5.3.1 Establishment of patient centered care and therapeutic relationship
All All 1,3,4,5
2 1
5.3.2 Management of patients with blood product transfusion
All 1,2,3,4,5,6,8
1,3,4 1,2,3 1,2,3 2,3,4,5,9,10.11
5.3.3 Management of patients with CVADs All 1,2,3,4,5,6,8
1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9,1011
5.3.4 Management of patient with complex Haematological conditions
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.5 Management of patients with chemotherapy and biotherapy for haematological malignancies
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.6 Management of HSCT (Allogeneic and Autologous) patients, including pre and post transplantation coordination and management
All All 1,2,3,4,5
1,2,4 1,2 2,3,4,5,9
1
5.3.7 Management of patients with post HSCT All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
10
transplantation relapses
5.3.8 Management of patients with inherited anaemia
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.9 Management of patients with inherited bleeding disorders
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.10 Management of patients with Acquired coagulation disorders, thrombocytopenia and haemophilia
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.11 Management of patients with Leukemia All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.12 Management of patients with Lymphomas
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.13 Management of patients with Multiple Myeloma
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.14 Management of patients with Aplastic Anaemia
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.15 Management of patients with haematological conditions on palliative care, pain management, psychological support and end of life care
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.16 Management of patients undergone Haematological procedures
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.17 Management of patients with apheresis All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.18 Infection control for Haematological and HSCT patients
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.3.19 Management of patients with haematological conditions undergone radiotherapy
All All 1,3,4,5
1,2,4 1,2,3,7
2,3,4,5,9
1
5.4 Development of nursing service and nurse-led clinic
All 5,6 1,2,3,4,5,6,
2,5 1,2
5.5 Legal and ethical issues 3,8 1,2,4 1,4 1,4,14
5.6 Quality and risk management 1,3,4, 1,2,3,4,5,6,
2,3,4,5
All 1
5.7 Management and leadership skills All 7 1,2,3,4,5,6
1,2,3,4,5,6
4,5,6,7
9,10, 11,12,13
1,2
5.8 Facilitate change and adopt evidence-based practice in nursing care
5 1,5 1,5,6 2,3,5,6,7
1,9,11,12,13,14
1,2
11
VI Oncology Nursing Sub-Specialty Module Reference: Gobel B. M., Triest-Robertson S. & Vogel W.H. (Eds). (2015). Advanced Oncology Nursing Certificate Review and Resources Manual. Pittsburgh: Oncology Nursing Society. 6.1 Prevention, Early detection and Screening of Cancer 6.1.1 Epidemiology 6.1.2 Prevention 6.1.3 Cancer screening and diagnostic test 6.1.4 Public participation in prevention, screening and early detection
6.2 Diagnosis and Staging of Cancer 6.2.1 Pathophysiology of cancer 6.2.2 Classification and staging 6.2.3 Diagnostic measures for specific cancer types
6.3 Treatment Modalities a) Surgery b) Systemic therapy: chemotherapy, biological agents, hormone and targeted
therapies c) Radiation therapy d) Concurrent combination therapy e) Hematopoietic stem cell transplant f) Complementary alternative health care
6.4 Knowledge of Cancer Diseases 6.4.1 Management of patients with a) Breast cancer b) Brain and central nervous system cancer c) Colorectal cancer d) Gastrointestinal cancer e) Genitourinary cancer f) Gynecological cancer g) Head and neck cancer h) Leukemia i) Lung cancer j) Lymphomas K) Melanoma l) Myelomas m) Prostate cancer
6.5 Symptom and Treatment Management 6.5.1 Oncology emergencies a) Disseminated intravascular coagulation (DIC) b) Extravasations c) Febrile neutropenia d) Hypercalcemia e) Hypersensitivity f) Increased intracranial pressure g) Malignant bowel / urinary obstruction
12
h) Neoplastic cardiac tamponade i) Pneumonitis j) Sepsis K) Spinal cord compression l) Superior vena cava obstruction m) Syndrome of inappropriate antidiuretic hormone (SIADH) n) Tumour lysis syndrome 6.5.2 Treatment delivery device and systems 6.5.2.1 Role and types and safe management of treatment delivery devices (e.g.
peripheral and central venous access devices, infusion pumps) 6.5.2.2 Assessment, care and maintenance of venous access devices 6.5.2.3 Patient education and subsequent monitoring 6.5.3 Management of disease symptoms and treatment related side effects
including alternations in the followings a) Bone marrow function b) Mobility c) Skin / mucosal integrity d) Neurological status e) Mental status f) Circulation g) Ventilation h) Gastrointestinal function i) Metabolic function j) Urinary function k)
l) Comfort i.e. Pain Psychosocial status
6.6 Supportive Care 6.6.1 Patient diversity 6.6.2 Sexuality and intimacy 6.6.3 Patient and family support throughout the cancer continuum 6.6.4 Rehabilitation 6.6.5 Survivorship 6.6.6 Palliative and End-of-Life care 6.6.7 Bereavement
6.7 Continuity of Care 6.7.1 Navigate the patient in the health care system 6.7.2 Inter-professional health care team communication and collaboration
6.8 Ethics, Legal Obligations and Research 6.8.1 Ethical principles in care of cancer patient 6.8.2 Ethical dilemmas 6.8.3 Legal obligations 6.8.4 Purpose and design of research studies 6.8.5 Ethical principles associated with research
6.9 Development of Nurse-led Clinics 6.10 Facilitate change and adopt evidence-based practice in nursing care
13
6.11 Quality and risk management 6.12 Management & leadership 6.10 Design and Framework of Oncology Nursing Sub-Specialty Module
The Oncology Nursing Sub-Specialty Module is designed under the competency framework (appendix 2) of HKCMN. Below indicated the Sub-Specialty Module matching the competency framework:
Subject areas Domains
1 2 3 4 5 6 7 6.1 Prevention, Early Detection and Screening of Cancer
2,3,5,9,10,11 1,2,3,4,5,6,8 1,2 1,4 1,2,3,4,5,8,
9,10 1
6.2 Diagnosis and Staging of cancer
1,2,3,4,5,6,7, 9,10
1,3,4,6,8 2 1,6 1,2,5,8 1
6.3 Treatment Modalities
a) Surgery all all 1,2,3,4,5 2,4,5,6 1,2,3,4,5,6 1,2,3,4,5,6,7,8,
9,10,11,12 1
b) Systemic therapy all all 1,2,3,4,5 2,4,5,6 1,2,3,4,5,6 1,2,3,4,5,6,7,8,
9,10,11,12 1
c) Radiation therapy all all 1,2,3,4,5 2,4,5,6 1,2,3,4,5,6
1,2,3,4,5,6,7,8, 9,10,11,12
1
d) Concurrent combination therapy
all all 1,2,3,4,5 2,4,5,6 1,2,3,4,5,6 1,2,3,4,5,6,7,8,
9,10,11,12 1
e) Hematopoietic stem cell transplant
all all 1,2,3,4,5 2,4,5,6 1,2,3,4,5,6 1,2,3,4,5,6,7,8,
9,10,11,12 1
f) Complementary alternative health care
1,2,6,7,8,9,11 all 1,2,3,4,5 4 2,8,9,10
6.4 Knowledge of Cancer Diseases – Management of Patient with
a) Breast cancer all all all all all all all
b) Brain and central nervous system cancer
all all all all all all all
c) Colorectal cancer all all all all all all all
d) Gastrointestinal cancer all all all all all all all
e) Genitourinary cancer all all all all all all all
f) Gynecological cancer all all all all all all all
g) Head and neck cancer all all all all all all all
h) Leukemia all all all all all all all
i) Lung cancer all all all all all all all
j) Lymphomas all all all all all all all
k) Melanoma all all all all all all all
l) Myelomas all all all all all all all
m) Prostate cancer all all all all all all all
6.5 Symptom and Treatment Management
6.5.1 Oncology emergencies
a) Disseminated intravascular coagulation (DIC)
1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
b) Extravasations 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
c) Febrile neutropenia 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
d) Hypercalcemia 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
e) Hypersensitivity 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
f) Increased intracranial pressure
1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
g) Malignant bowel / urinary obstruction
1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
h) Neoplastic cardiac tamponade
1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
i) Pneumonitis 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
j) Sepsis 1,2,3,4,5,6,7, all all all all 1,2,3,4,5,6,7,8, 1
14
8,9,11 9,10,11,12
k) Spinal cord compression 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
l) Superior vena cava obstruction
1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
m) Syndrome of inappropriate antidiuretic hormone (SIADH)
1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
n) Tumour lysis syndrome 1,2,3,4,5,6,7, 8,9,11
all all all all 1,2,3,4,5,6,7,8,
9,10,11,12 1
6.5.2 Treatment delivery device and systems
6.5.2.1 Role and types and safe management of treatment delivery devices
2,10 3
3,7 1,5,6,8,10,11
6.5.2.2 Assessment, care and maintenance of venous access devices
1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 all 1,2,3 all
1,2,3,4,5,6,7,8, 9,10,11
1
6.5.2.3 Patient education and subsequent monitoring
1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 1,2,3 3,4,5,6 all
1,2,3,4,5,6,7,8, 9,10,11
1
6.5.3 Management of disease symptoms and treatment of related side effects including alterations in the following
a) Bone marrow function 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
b) Mobility 1,2,3,4,6,7,9, 11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
c) Skin/ mucosal integrity 1,2,3,4,6,7,9, 11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
d) Neurological status 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
e) Mental status 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
f) Circulation 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
g) Ventilation 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
h) Gastrointestinal function 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
i) Metabolic function 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
j) Urinary function 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
k) Comfort i.e. Pain 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
l) Psychosocial status 1,2,3,4,5,6,7, 8,9,11
1,2,3,4,5,6,8 3 1,2,3,4,6 all all 1
6.6 Supportive Care
6.6.1 Patient diversity 2 all 3 4 3,7,8 1
6.6.2 Sexuality and intimacy 1,2,9,11 all 3 2,3,4 3,7,8 1
6.6.3 Patient and family support throughout the cancer continuum
1,2,3,11 all 3
4 1,8 1
6.6.4 Rehabilitation 1,2,3,4,6,7,8, 10,11
all 3
1,2,3,4,5,6 3,4,5,6,7,8 1
6.6.5 Survivorship 1,2,5,9,10,11 all 3
2,4,6,7
1,2,3,4,5,6,8,9 10,11,13,14
all
6.6.6 Palliative and End-of-Life care
1,2,3,4,5,6,7, 8,9,11
all 3 1,2,6 all all all
6.6.7 Bereavement 1,2,3,4,5,6,7, 8,9,11
all 3 1,2,6 all all all
6.7 Continuity of Care
6.7.1 Navigate the patient in the health care system
1,2,3,7,9,10, 11
1,3,4,8 1 4 4,6 2,8,9
6.7.2 Interprofessional health care team communication and collaboration
1,2,3,7,10
4 6
13
6.8 Ethics, Legal Obligations and Research
6.8.1 Ethical principles in care of cancer patient
3 3,4
2,3,8,9,11,14 1
6.8.2 Ethical dilemmas 3 3,4 2,3,8,9,11,14 1
6.8.3 Legal obligations 3 3,4 2,3,8,9,11,14 1
6.8.4 Purpose and design of research studies
6
3,6 1,5,6,7 1,4,5,6,7 1
15
6.8.5 Ethical principles associated with research
3,6 3,4 2,3,8,9,11,14 1
6.9 Development of nurse-led clinics
all all 1,3,4,5,6 all all 1,2,8,9,10 all
6.10 Facilitate change and adopt evidence-based practice in nursing care
all all 1,2,3,5 5 2,3,7 3,4,5,9,10 all
6.11 Quality and risk management
9 1,3,4 all 2,3,4,5,7 all 1
6.12Management & leadership all all all 3,4,5,6,7 all all
16
VII Renal Nursing Sub-specialty Module 7.1
Fundamental Module 7.1.1 Applied Anatomy & Physiology 7.1.2 Electrolyte & Acid-base Balance 7.1.3 Investigations on Renal Diseases
7.1.4 Health assessment module 7.1.4.1 Assessment of patient prior to renal replacement therapy (RRT), blood purification
or renal palliative care 7.1.4.2 Assessment of patient on either type of therapeutic therapy 7.1.4.3 Nutritional assessment of patient on various therapeutic therapy
7.2 Clinical manifestation and management of Renal Diseases (medical): 7.2.1 Primary glomerular disease:
7.2.1.1 Rapidly progressive glomerulonephritis (GN) 7.2.1.2 Membranoproliferative GN 7.2.1.3 Mesanginal proliferative GN 7.2.1.4 Minimal change diseases 7.2.1.5 Focal segmental glomerulosclerosis 7.2.1.6 Membraneous Nephropathy 7.2.1.7 IgA Nephropathy 7.2.2 Secondary Glomerular disease:
7.2.2.1 Autoimmune: SLE, Polyarteritis nodosa 7.2.2.2 Good pasture’s syndrome 7.2.2.3 Post-infectious glomerulonephritis: Hepatitis B or C virus 7.2.2.4 Herpes Zoster, HIV 7.2.2.5 Hypertension nephropathy 7.2.2.6 Renal vascular disease: Wegener’s granulomatosis, Henoch- Schonlein purpura,
7.3.3.1.2 Care of patient with PD therapy 7.3.3.1.3 Nursing management of patient with complications of PD
7.3.3.2 Hemodialysis (HD), hemofiltration (HF) 7.3.3.2.1 Types of vascular access for HD and its nursing management
7.3.3.2.2 Water treatment system for HD 7.3.3.2.3 Anticoagulation of HD
7.3.3.2.4 Mode of hemodialysis 7.3.3.2.5 Mode of hemofiltration 7.3.3.2.6 Care of patient with hemodialysis therapy 7.3.3.2.7 Nursing management of patient with complications of HD 7.3.3.2.8 Pediatric Hemodialysis & its nursing management
7.3.3.3 Renal transplantation 7.3.3.3.1 Pre-operative management of patient with renal transplantation
7.3.3.3.2 Post-operative management of patient with renal transplantation 7.3.3.3.3 Management of patient with renal graft rejection 7.3.3.3.4 Organ Transplant & Procurement : Ethical & Legal Implication on Services 7.3.3.3.5 Management of potential deceased and living donors 7.3.3.3.6 Tissue typing and matching 7.3.3.3.7 Renal transplant and immunology
7.3.4 Nursing management of patient with Diabetes on dialysis 7.3.5 Therapeutic blood purification
7.3.6 Renal palliative care 7.3.6.1 Physical and psychological symptoms management
7.3.6.2 Care of patient and family 7.3.6.3 Care of the dying person in various settings 7.3.6.4 Advance care planning
7.4 Training of patient for home based renal dialysis 7.4.1 Training of patient with PD therapy 7.4.2 Training of patient with HD therapy
7.5 Rehabilitation of patient with end stage renal failure
7.6 Infection control in renal unit
7.7 Development of Nurse Led Clinics
7.8 Legal and ethical issues
7.8.1 Ethical principles in caring of patients with renal failure 7.8.2 End of life care 7.8.3 Ethical dilemmas 7.8.4 Legal obligations
18
7.9 Quality and risk management
7.10 Management and leadership skills
7.11 Facilitate change and adopt evidence-based practice in nursing care
7.12 Research 7.12.1 Research Proposal 7.12.2 Ethical principles associated with research
7.13 Data Management
7.13.1 Renal Registry 7.13.2 Clinical Audit
7.14 Design and Framework of Renal Nursing Sub-Specialty Module The Renal Nursing Sub-Specialty Module is designed under the competency framework (appendix 2) of HKCMN. Below indicated the Sub-Specialty Module matching the competency framework:
No. Subject Areas Domains
1 2 3 4 5 6 7
7.1 Fundamental Module
7.1.1 Applied Anatomy & Physiology 1,3,4,5,6,7,11
1
7.1.2 Electrolyte & Acid-base Balance
1,3,4,5,6,7,8,11
1,2,3,6
1,2 1 4,5,7
7.1.3 Investigation on Renal Diseases 1,3,4,5,6,7,8,11
1,2,3,6
1,2 1 4,5,7
7.1.4 Health assessment module
7.1.4.1 Assessment of patient prior to renal replacement therapy (RRT), blood purification or renal palliative care
All All 1,3 1,2,3,5,6
1,3, 4,6
8
7.1.4.2 Assessment of patient on either type of therapeutic therapy
All 1,4, 1,3, 4,6
8
7.1.4.3 Nutritional assessment of patient on various therapeutic therapy
All 1,4, 1,2,3,4
1,2,3,5,6
1,3, 4,6
8
7.2 Clinical manifestation and management of Renal Diseases (medical)
7.8.1 Ethical principles in caring of patients with renal failure
3 3,4
2,3,8,9,11,14
1
7.8.2 End of life care 3 3,4
2,3,8,9,11,14
1
7.8.3 Ethical dilemmas 3 3,4
2,3,8,9,11,14
1
7.8.4 Legal obligations 3 3,4
2,3,8,9,11,14
1
7.9 Quality and risk management 9 1,3,4, 4, 5,6 All 2,3,4,57
All 1
7.10 Management and leadership skills All 7 All All 3,4,5,6,7
All 1,2
7.11 Facilitate change and adopt evidence-based practice in nursing care
9 5 1,5,6 1,3,,5,6
2,3,5,6,7
1,6,7,9,11,12,13,14
1,2
7.12 Research
7.12.1 Research Proposal 6
3,6
1,5,6,7
1,4,5,6,7
1
7.12.2 Ethical principles associated with research 3,6 3,4
2,3,8,9,11,
14 1
22
7.13 Data Management
7.13.1 Renal Registry 9,11 , 1 5 6 3,4,5,12,13,14
1
7.13.2 Clinical Audit 2,3,4,5,6,7,8,9,10,11
1,2,3,4,5,6,8
1,2,3 All 1,2,3,4,5,6
3,4,5,11,12,13,
1, 2
23
VIII Respiratory Nursing Sub-specialty Module 8.1 Health Assessment 8.1.1 Applied anatomy and patho-physiology, etiology in respiratory patient care 8.1.2 Screening, diagnosis and related investigation / assessment for respiratory diseases 8.1.3 Screening of the infectious disease and safe environment control in preventing nosocomial
infections 8.1.4 Screening of patients according to updated Government supported programs such as Nurse &
Allied Health Clinic 8.2 Establishment of Patient Centered Care Therapeutic relationship 8.3 Multi-disciplinary Collaboration such as case conference and pre-discharge plan 8.4 Management patients with: 8.4.4 Receiving Interventional Pulmonology such as bronchoscopy, pleuroscopy & endobronchial
empyema 8.4.13 Lung Cancer 8.4.14 Pulmonary Tuberculosis 8.4.15 Extra-pulmonary Tuberculosis 8.4.16 Multidrug Resistant / Extensive Drug Resistant Tuberculosis 8.4.17 Novel Viral Infection 8.4.18 Critical Respiratory conditions Receiving Oxygen Therapy 8.4.19 Critical Respiratory conditions with Non-invasive Ventilation (NIV) or Invasive Mechanical
Ventilation (IMV) 8.4.20 Tracheostomy 8.4.21 Chest Drain, Pigtail Drain & Indwelling Pleural Catheter (IPC) 8.4.22 Sleep Breathing Problem 8.5 Pulmonary Rehabilitation Program 8.6 Health education to patients Receiving: 8.6.1 Inhaled Medications 8.6.2 Home Oxygen Therapy 8.6.3 Home Non-invasive Ventilation including BiPAP & CPAP 8.6.4 Home Invasive Ventilation 8.6.5 Outpatient Parental Antibiotic 8.6.6 Chronic Disease Self-Management, Exacerbation Management and Patient Empowerment 8.7 Nurse Led Clinic – planning, development and operation 8.8 Develop Smoking Cessation Program 8.9 Patient advocacy and End-of-Life Care 8.10 Facilitate change and adopt evidenced based practice in nursing care 8.11 Initiate improvement strategies in quality and risk management
24
8.12 Design and Framework of Respiratory Nursing Sub-Specialty Module The Respiratory Nursing Sub-Specialty Module is designed under the competency framework (appendix 2) of HKCMN. Below indicated the Sub-Specialty Module matching the competency framework:
Subject areas Domains
1 2 3 4 5 6 7
I. Health Assessment 1. Applied Anatomy & patho-
physiology, etiology for Respiratory diseases
1,2,3,4,5,8
2. Screening, diagnosis and related investigation / assessment for Respiratory Diseases
3,5,6,7 1,3,4,8 1 5
3. Screening of the infectious disease and safe environment control in preventing nosocomial infections
All 1,2,3,4,8 1,2,3 1,2,3,5 1
4. Screening of patients according to updated Government supported programs such as Nurse & Allied Health Clinic
All 1,2,3,4,8 1,2,3 1,2,3,5 1
II. Establishment of Patient Centered Care Therapeutic relationship
All All
1,3,4,5 2 1
III. Multi-disciplinary Collaboration such as case conference and pre-discharge plan
All All
1,3,4,5 2 1
IV. Management of patients 1. Receiving Interventional
Pulmonology such as bronchoscopy, pleuroscopy & endobronchial ultrasound (EBUS)
2. Home Oxygen Therapy All 1,2,3,4,5,8 1,2,3,4,5 1, 2, 4 1 5 1
3. Home Non-invasive Ventilation including BiPAP & CPAP
All 1,2,3,4,5,8 1,2,3,4,5 1, 2, 4 1 5 1
4. Home Invasive Ventilation All 1,2,3,4,5,8 1,2,3,4,5 1, 2, 4 1 5 1
5. Outpatient Parental Antibiotic All 1,2,3,4,5,8 1,2,3,4,5 1, 2, 4
6. Chronic Disease Self-Management, Exacerbation Management and Patient empowerment
All 1,2,3,4,5,8
All 1, 2, 4 1 5 1
VII. Nurse Led Clinic All All 5,6 1,2,3,4,5,6 2,5 2,3 1
VIII. Develop Smoke Cessation Program
All 1,2,3,4,5,8
All 1, 2, 4 1 5 1
IX. Patient Advocacy and End of Life care
All 1,2,3,4,5,8 1 3 1,4 2,5,9 1
X. Facilitate change and adopt evidence based practice in nursing care
1,2,3,5
2,3,7
3,4,5,9,10
XI. Develop and foster patient safe environment and initiate improvement strategies in quality and risk management
3 2,3,4,8 3,4 1,2,3, 4,5,6
1,2,3,7
4,5,6,7,9 10,11 12,13
1,2
26
IX. Rheumatology Nursing Sub-Specialty Module
9.1 Clinical aspect of Rheumatology 9.1.1 Musculoskeletal system, immune system, pain perception and pathways 9.1.2 Screening, diagnosis, related investigation and nursing assessment for Rheumatic Diseases
a) Musculoskeletal examination b) Functional assessment c) Joint assessment d) Disease Activity Score (DAS 28) e) CDAI/ SDAI f) Bath Indices for Ankylosis Spondylitis (AS) g) PASI score h) SELENA-SLEDAI i) SLICC j) Biomarkers k) Autoantibodies l) Blood result interpretation m) Radiology examination: Magnetic Resonance Imaging, Computerized Tomography,
9.1.4 Dermatological perspective in rheumatic diseases with distinct features: Lupus Erythematosus, Dermatomyositis, Scleroderma, Rheumatoid Arthritis, Vasculitis
9.1.5 Orthopaedic perspective in rheumatic diseases: operative management in hand, knee & hip and foot & ankle (e.g. Joint replacement, joint reconstruction)
9.1.6 Management of special situations in patient with rheumatic diseases: sepsis, operation, malignancy, pregnancy, vaccination, and disease flare up
9.1.7 Medications management in rheumatic diseases a) Analgesics b) Non-steroidal anti-inflammatory drugs c) Steroid therapy d) Conventional disease modifying anti-rheumatic drugs (DMARDs) and
immunosuppressants e) Bone protection agents
27
9.2 Biologic Care 9.2.1 Types of biologics 9.2.2 Patient assessment and screening for biologic therapy 9.2.3 Counseling for biologic therapy: financial issues, pregnancy, family planning 9.2.4 Delivery of biologic infusion 9.2.5 Education of self-injection 9.2.6 Safety monitoring 9.2.7 Data management on biologic registry 9.3 Patient Education and Counseling 9.3.1 Patient’s journey, stage of changes and coping strategies 9.3.2 Formulate and implement patient education incorporating patient’s physical, psychosocial, and
developmental needs 9.3.3 Identify and assist patient’s concordance to treatment 9.3.4 Patient empowerment and self-management 9.3.5 Educate and counsel patient and/or support system regarding medications, problem solving,
communication skills, stress management, and safety issues 9.3.6 Educate and advise in Multidisciplinary Team (MDT) approach including physiotherapy,
occupational therapy, dietary management, podiatry and social worker 9.4 Psychosocial care 9.4.1 Comprehensive psychological and social assessment 9.4.2 Psychosocial impact of rheumatic diseases 9.4.3 Acknowledge depression and recognize early signs associated with various rheumatic disease
processes 9.4.4 Effective communication and counseling 9.4.5 Psychosocial aspect and current social resources from Medical Social Worker’s perspective 9.5 Care of patients with telecommunication methods 9.6 Coordination and collaboration of care 9.6.1 Collaborate with physicians, nurses, dietitian, social workers, psychologists, occupational
therapists, physiotherapists, podiatrists and community agencies in planning appropriate management of patient problems
9.6.2 Explore and collaborate the community resources which provide psychotherapeutic services: Community Rehabilitation Network, Hong Kong Arthritis & Rheumatism Foundation
9.7 Develop nurse-led clinic 9.8 Develop care-pathway and care model on Rheumatic diseases 9.9 Develop and foster patient safe environment and initiate improvement strategies in quality
and risk management 9.10 Develop/review clinical care protocols and facilitate change by adoption of evidence-based
practice in Rheumatology care 9.11 Management and leadership skills
9.12 Design and Framework of Rheumatology Nursing Sub-Specialty Module The Rheumatology Nursing Sub-Specialty Module is designed under the competency framework (appendix 2) of HKCMN. Below indicated the Specialty Module matching the competency framework:
Subject areas Domains 1 2 3 4 5 6 7
9.1 Clinical aspect of Rheumatology
9.1.1 Musculoskeletal system, immune system, pain perception and pathways
3,4,5,6,7,11
2,3,5 --- --- --- 1
9.1.2 Screening, diagnosis, related investigation and nursing assessment for Rheumatic
1,3,4,5,6,7,8, 11
1,2,3,6 1,2 1,2,5 1 4,5,7 1
28
Diseases 9.1.3 Clinical features, assessment and management of patients with:
a) Inflammatory Arthritis – RA, SpA
All All --- --- 1,2,3,4 1 1
b) CTD – SLE, Scleroderma, Inflammatory myopathies
All All --- --- 1,2,3,4 1 1
c) Gout, Tophaceous gout, Pseudogout
All All --- --- 1,2,3,4 1 1
d) Infection related joint diseases: Septic Arthritis, Reactive Arthritis
All All --- --- 1,2,3,4 1 1
e) Metabolic bone disease – Osteoporosis, Endocrine related arthopathy
9.1.4 Clinical evaluation for patient with inflammatory arthritis with different assessment tools
All 1,2,3,6 --- --- 1,2,3,4 2 1
9.1.5 Dermatological perspective in rheumatic diseases with distinct features: Lupus Erythematosus, Dermatomyositis, Scleroderma, Rheumatoid Arthritis, Vasculitis
All All --- --- 1,2,3,4 1 1
9.1.6 Orthopaedic perspective in rheumatic diseases: operative management in hand, knee & hip and foot & ankle
1,2,3,6,7,9,10,11
1,2,3,4,5,8
--- --- 1,2,3,4 1,3 1
9.1.7 Management of special situations in patient with rheumatic disease: Sepsis, operation, Malignancy, Pregnancy, Vaccination, and Disease Flare Up
All All --- --- 1,2,3,4,5,7
1,2,3,4,5,6,7,8
1
9.1.8 Medications management in rheumatic disease
All All --- 1,2,5 All 1,2,3,4,5,6,7,8
1
9.2 Biologic Care 9.2.1 Types of biologics 2,3,4,5,7,8
,9, 11
2,3,4,8 --- --- All 1,2,3,5,6,7,8
1
9.2.2 Patient assessment and screening for biologic therapy
All 1,2,3,4,5,6,8
--- --- All 1,2,3,5,6,7,8
1
9.2.3 Counseling for biologic therapy: financial issues, pregnancy, family planning
All 1,2,3,4,5,6,8
--- --- All 1,2,3,5,6,7,8
1
9.2.4 Delivery of biologic infusion
All All --- All All 2,3,5,6,7,8 1
9.2.5 Education of self-injection All 1,2,3,4,5,6,8
--- All All 2,3,5,6,7,8 1
9.2.6 Safety monitoring All All --- All All 1,2,3,5,6,8 1 9.2.7 Data management on biologic registry
9, 11 --- --- --- All 4,5,6,7 1
9.3 Patient Education 9.3.1 Patient’s journey, stage of changes and coping strategies
1,2,3,6,8,9 All 1,2 --- --- --- 1
9.3.2 Formulate and implement patient education incorporating
All All All 1,5 --- 2,3,5,6,7 1
29
patient’s physical, psychosocial, and developmental needs 9.3.3 Identify and assist patient’s concordance to treatment
All All 1,2 --- 4 --- 1
9.3.4 Patient empowerment and self-management
All All All 2,3,4,5,6 1,4,6 1,2,8,9,11,12
1
9.3.5 Educate and counsel patient and/or support system regarding medications, problem solving, communication skills, stress management, and safety issues
All All All 1 --- 2,3,5,6,7 1
9.3.6 Educate and advise in MDT approach including physiotherapy, occupational therapy, dietary management, podiatry and social worker
All All All 1,6 --- 2,3,5,6,7 1
9.4 Psychosocial care 9.4.1 Comprehensive psychological and social assessment
All 1,4,5,6,8 1 --- --- 3,8 1
9.4.2 Psychosocial impact of rheumatic diseases
All All 1 --- --- ---- 1
9.4.3 Acknowledge depression and recognize early signs associated with various rheumatic disease processes
All All 1 --- --- --- 1
9.4.4 Effective communication and counseling
All All 1 --- --- 2,3,8 1
9.4.5 Psychosocial aspect and current social resources from Medical Social Worker’s perspective
1,2,7,9,11 All 1,4,5 --- --- 8 1
9.5 Care of patient with telecommunication methods
All All All All All 2,3,5,7,8 1
9.6 Coordination and collaboration of care
9.6.1 Collaborate with physicians, nurses, dietitian, social workers, psychologists, occupational therapists, physiotherapists, podiatrists and community agencies in planning appropriate management of patient problems
All All All 1,6 1,4 9,10,11 1
9.6.2 Explore and collaborate the community resources which provide psychotherapeutic services: Community Rehabilitation Network, Hong Kong Arthritis & Rheumatism Foundation
All All All 1,5 1,4 9,11,13 All
9.7 Develop nurse-led clinic All All All All All 1,2,8,9,11,12
All
9.8 Develop care-pathway and care model on Rheumatic diseases
All 1,2,3,4,5,8
All All 1,4,6 1,2,8,9,11,12
All
9.9 Develop and foster patient safe environment and initiate improvement strategies in quality and risk management
All All 3,4 All 1,2,3,7 4,5,6,7,9,10, 11,12,13
All
9.10 Develop/ review clinical care protocols and facilitate change by adoption of evidence-based practice in rheumatology care
9 5 1,5,6 1,3,5,6 2,3,5,6,7 1,6,7,9,11,12,13,14
1,2
9.11 Management and leadership skills
All 7 All All 3,4,5,6,7 All 1,2
30
X Course Calendar The College accepts - Application for Associate Membership- every February. - Conduction of Membership Certification Examination (MCQ Examination) - every June. - Application for Ordinary Membership- every July. - Conduction of Fellow Membership Exit Assessment- every October. - Application of Fellow Member – every November.
XI Fellow Membership Exit Assessment 11.1 After completion of the Sub-Specialty Module and recommended by the mentors, the Ordinary
Members are eligible to attempt assessment stipulated by HKCMN for recommendation to the Hong Kong Academy of Nursing to be Fellow Members.
11.2 Assessment could be: case study and viva; or project and viva (pre-arrangement by Sub Specialty). 11.3 Assessment Panel is to assess the submitted case study/ project and will sit in the viva. Composition of the Assessment Panel:
- Fellow of the sub-specialty - invited physician of the sub-specialty - invited nurse expert.
11.4 Case study:
The candidate reviews the log book and selects a case for presentation as agreed by the mentor. The case study should cover the essential topics as stipulated by HKCMN. The word limit of the case study should be 2500 words+10%.
11.5 Project:
The candidate submits project outline which is approved by the mentor. The project could be evidenced based practice project, clinical guideline development or initiation of a change in practice. The word limit of the project paper should be 4000 words +10%. The project should be able to demonstrate at least two of the following: - Innovativeness or originality of the work - An impact to the practice of specialty nursing - A contribution to improve current practice in patient care and education - A contribution to research / new knowledge development in related specialty nursing
11.6 Viva
11.6.1 The duration of the viva session is one and an half hour and consists of two parts. 11.6.2 Part 1 case study/project : The Candidate is to present the gist of the case study/project to the Assessment Panel. Time limit of the presentation is 15 minutes. The members of the Assessment Panel will then raise follow up questions related to the case study/project to critically assess the candidates’ clinical competence and application of theory to clinical practice to ensure patient safety, and enhance quality of care. The duration of the viva on this part is not to be less than 45 minutes. 11.6.3 Part 2 EBP and Professional Nursing knowledge : The members of the Assessment Panel will assess the candidate’s proficiency in the aspect of linking evidence based practice to clinical practice, development of professional nursing knowledge through nursing research, contribution of nursing in the health care team and health promotion and protection of health to the community at large. The duration of the viva on this part is not to be less than 30 minutes.
31
11.7 The passing grade of Fellow Assessment is “Satisfactory”. 11.8 Eligibility for recommendation to the Hong Kong Academy of Nursing to be considered as Fellow Members.
- Holder of Registered Nurse (RN) Certificate issued by Nursing Council of Hong Kong and with valid Practicing Certificate
- At least 6 years accumulative specialty experience in the most recent 9 years. Part of the 6 years sub-specialty experience must be in the current 3 years.
- Ordinary Member of HKCMN and HKAN - Passed Fellow Assessment - Demonstrated evidence of clinical leadership and significant contribution to nursing
profession
- Achieved 60 Continued Nursing Education points for every 3 year cycle of which 45 CNE points are specialty related
- Recommended by 2 Fellows (Advanced Medicine) of PHKAN, then via the College to HKAN - Need to apply for Fellow Membership within 3 years upon becoming eligible, otherwise the
eligibility would lapse.
XII Award Fellow of Hong Kong Academy of Nursing (Medicine-Haematology) Fellow of Hong Kong Academy of Nursing (Medicine-Oncology) Fellow of Hong Kong Academy of Nursing (Medicine-Renal) Fellow of Hong Kong Academy of Nursing (Medicine-Respiratory) Fellow of Hong Kong Academy of Nursing (Medicine-Rheumatology)
32
XIII Appendix – 1
Core Module
Holder of Registered Nurse (RN) Certificate issued by Nursing Council of Hong Kong and with valid Practicing Certificate
Worked in Medical Nursing related specialty for at least an accumulative 4 years in the most recent 6 years (among the 4 years, the nurse must acquire a minimum of 1 year of subspecialty that he/she desired to take later)
500 theory hours: Generic (167); Advance (167) and Specialty (167) 5oo clinical hours: 50-100% supervised practice, 50% work placement; and complete not less than
75% of Log Book which demonstrated active participation in reflective learning The core module is to be completed within 4 years Completed Master Degree of Nursing or Health Care related
At least 4 years accumulative medical nursing related in the recent 6 years (among the 4 years, the nurse must acquire a minimum of 1 year of subspecialty that he/she desired to take later)
Self-declaration of NO Criminal Conviction or professional misconduct
Recommend by designated mentor Passed the Membership examination
Ordinary Member
Hong Kong College of Medical Nursing
Advanced Practice Nursing Certification Program
Road Map
33
Sub - Specialty Module
The Ordinary Member must acquire a minimum of 1 year in the subspecialty before he/she is eligible to take the sub-specialty training among the 10 sub-specialties below:
The Ordinary Member will complete the specialty Module in not less than three years The duration of elective sub-specialty education program (both theory learning and clinical
practice) should be a minimum of 1 year and a maximum of 2 years He/she is under the guidance of a designated mentor to:
Complete not less than 75% of the Log Book, but fulfill the mandatory items Complete not less than 2 case presentations/studies within the framework of Clinical Log
Sheet Lead/ active participate in CQI, research, mortality and morbidity meeting, journal club
At least 6 years accumulated medical nursing related specialty experience in the most recent 9 years
The 6 years specialty experience (of which 4 years are related to the subspecialty) must be in the current 3 years
Self-declaration of NO Criminal Conviction or professional misconduct
Recommend by 2 Fellows
Evaluation passed and recommended by the designated mentor
Take assessment as stipulated- case presentation or viva or project
Proof of significant contribution to the profession
Member needs to apply for Fellow Membership within 3 years upon becoming eligible, otherwise the eligibility would lapse
Approved by HKAN
Fellow
34
XIV APPENDIX 2
Hong Kong College of Medical Nursing
The Competence Framework of 7 Domains
The Advanced Practice Nursing Certification Program is designed under the competence framework
of the following 7 domains
Domain 1 Managing clients with complex healthy conditions
1 Manages complete episode of care for complicated health cases and
refers aspects of care to own and other professions
2 Provides case management services to meet multiple client health care needs
3 Plans and implements diagnostic strategies and therapeutic interventions
to help clients with unstable and complex health care problems regain
stability and restore health in collaboration with the client and
multidisciplinary health care team
4 Rapidly assesses client’s unstable and complex health care problems
through synthesis and prioritization of historically and immediately derived data
5 Selects, may perform, and interprets common screening and diagnostic
laboratory tests
6 Diagnoses and manages acute and chronic diseases while attending to the
illness experience
7 Diagnoses unstable and complex health care problems utilizing collaboration
and consultation with the multidisciplinary health care team as indicated by
setting, specialty, and individual knowledge and experience
8 Reviews medication regime and counsels clients concerning drug regimens, drug
side effects, and interaction
35
9 Assesses and adjusts plans for continuous management of client’s health
status by monitoring variation in wellness and illness
10 Obtains specialist and referral care for clients while remaining the primary care
provider
11 Monitors clients data base for follow up, consultation a, referral and outcome